The evolving field of biodefence: Therapeutic developments and diagnostics

被引:118
作者
Burnett, JC
Henchal, EA
Schmaljohn, AL
Bavari, S [1 ]
机构
[1] NCI, Dev Therapeut Program, Based Drug Discovery Grp, SAIC, Frederick, MD 21702 USA
[2] USA, Med Res Inst Infect Dis, Frederick, MD 21702 USA
关键词
D O I
10.1038/nrd1694
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The threat of bioterrorism and the potential use of biological weapons against both military and civilian populations has become a major concern for governments around the world. For example, in 2001 anthrax-tainted letters resulted in several deaths, caused widespread public panic and exerted a heavy economic toll. If such a small-scale act of bioterrorism could have such a huge impact, then the effects of a large-scale attack would be catastrophic. This review covers recent progress in developing therapeutic countermeasures against, and diagnostics for, such agents.
引用
收藏
页码:281 / 297
页数:17
相关论文
共 206 条
[1]  
Adler M, 1999, J APPL TOXICOL, V19, pS5, DOI 10.1002/(SICI)1099-1263(199912)19:1+<S5::AID-JAT606>3.0.CO
[2]  
2-M
[3]   Efficacy of a novel metalloprotease inhibitor on botulinum neurotoxin B activity [J].
Adler, M ;
Nicholson, JD ;
Hackley, BE .
FEBS LETTERS, 1998, 429 (03) :234-238
[4]   Molecular mechanisms of filovirus cellular trafficking [J].
Aman, MJ ;
Bosio, CM ;
Panchal, RG ;
Burnett, JC ;
Schmaljohn, A ;
Bavari, S .
MICROBES AND INFECTION, 2003, 5 (07) :639-649
[5]   Thio-derived disulfides as potent inhibitors of botulinum neurotoxin type B: Implications for zinc interaction [J].
Anne, C ;
Blommaert, A ;
Turcaud, S ;
Martin, AS ;
Meudal, H ;
Roques, BP .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (21) :4655-4660
[6]   Development of potent inhibitors of botulinum neurotoxin type B [J].
Anne, C ;
Turcaud, S ;
Quancard, J ;
Teffo, F ;
Meudal, H ;
Fournié-Zaluski, MC ;
Roques, BP .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (22) :4648-4656
[7]   Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation [J].
Arad, G ;
Levy, R ;
Hillman, D ;
Kaempfer, R .
NATURE MEDICINE, 2000, 6 (04) :414-421
[8]   Botulinum toxin as a biological weapon - Medical and public health management [J].
Arnon, SS ;
Schechter, R ;
Inglesby, TV ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Fine, AD ;
Hauer, J ;
Layton, M ;
Lillibridge, S ;
Osterholm, MT ;
O'Toole, T ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Swerdlow, DL ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08) :1059-1070
[9]   ANTIMICROBIAL SUSCEPTIBILITY TESTING OF FRANCISELLA-TULARENSIS WITH A MODIFIED MUELLER-HINTON BROTH [J].
BAKER, CN ;
HOLLIS, DG ;
THORNSBERRY, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (02) :212-215
[10]   The highly specific carbohydrate-binding protein cyanovirin-N: Structure, anti-HIV/Ebola activity and possibilities for therapy [J].
Barrientos, LG ;
Gronenborn, AM .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (01) :21-31